0.7304
price up icon4.34%   0.0304
pre-market  Vorhandelsmarkt:  .73   -0.0004   -0.05%
loading
Schlusskurs vom Vortag:
$0.70
Offen:
$0.71
24-Stunden-Volumen:
1.21M
Relative Volume:
1.18
Marktkapitalisierung:
$69.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-93.61M
KGV:
-0.3462
EPS:
-2.11
Netto-Cashflow:
$-71.16M
1W Leistung:
-17.93%
1M Leistung:
-36.49%
6M Leistung:
-42.49%
1J Leistung:
-42.49%
1-Tages-Spanne:
Value
$0.681
$0.732
1-Wochen-Bereich:
Value
$0.561
$0.93
52-Wochen-Spanne:
Value
$0.561
$2.11

Immunic Inc Stock (IMUX) Company Profile

Name
Firmenname
Immunic Inc
Name
Telefon
(332) 255-9818
Name
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Name
Mitarbeiter
90
Name
Twitter
@ImmunicInc
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
IMUX's Discussions on Twitter

Vergleichen Sie IMUX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMUX
Immunic Inc
0.7304 85.28M 0 -93.61M -71.16M -2.11
Biotechnology icon
ONC
Beone Medicines Ltd Adr
251.72 25.78B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.48 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3401 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.81 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
487.86 65.13B 14.09B 4.50B 2.96B 39.28

Immunic Inc Stock (IMUX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-25 Eingeleitet William Blair Outperform
2024-11-25 Eingeleitet H.C. Wainwright Buy
2024-09-09 Fortgesetzt Leerink Partners Outperform
2024-08-27 Eingeleitet B. Riley Securities Buy
2022-10-21 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-09-19 Fortgesetzt H.C. Wainwright Buy
2021-04-15 Eingeleitet Aegis Capital Buy
2021-03-24 Eingeleitet JMP Securities Mkt Outperform
2020-10-02 Eingeleitet SVB Leerink Outperform
2020-08-26 Eingeleitet Piper Sandler Overweight
2020-08-07 Fortgesetzt ROTH Capital Buy
2020-07-20 Eingeleitet BMO Capital Markets Outperform
2020-06-05 Eingeleitet Wedbush Outperform
2020-05-11 Eingeleitet H.C. Wainwright Buy
2020-03-25 Eingeleitet ROTH Capital Buy
2019-07-11 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Immunic Inc Aktie (IMUX) Neueste Nachrichten

pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic raises $65M in public offering to fund clinical trials - Proactive financial news

Jun 03, 2025
pulisher
Jun 02, 2025

Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic Showcases Breakthrough MS Drug Data at 6 Major Healthcare Conferences This Month - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic releases June conference schedule - Proactive Investors

Jun 02, 2025
pulisher
May 30, 2025

Immunic Announces $65 Million Public Offering - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress

May 30, 2025
pulisher
May 30, 2025

Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Immunic unveils pricing of $65M underwritten public offering - Proactive financial news

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic Inc. prices $65 million public offering - Investing.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Investing.com Nigeria

May 29, 2025
pulisher
May 28, 2025

Immunic launches public offering of warrants to fund clinical trials; shares down - MSN

May 28, 2025
pulisher
May 28, 2025

Immunic slides on planned equity raise - TradingView

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warr - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic announces public offering of warrants to fund trials By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warrants | IMUX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic Announces Public Offering to Fund Trials - TipRanks

May 28, 2025
pulisher
May 28, 2025

Biotech Immunic Launches Strategic Public Offering to Advance Inflammatory Disease Pipeline - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Immunic's IMU-856 shows promise as Celiac Disease Awareness Month draws to a close - Proactive Investors

May 27, 2025
pulisher
May 26, 2025

Immunic’s (IMUX) Buy Rating Reiterated at B. Riley - Defense World

May 26, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic F - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Immunic (IMUX) Price Target Lowered by B. Riley Securities | IMU - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic Financing Prospects | IMUX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

B. Riley Cuts Price Target on Immunic to $5 From $6, Keeps Buy Rating - marketscreener.com

May 23, 2025
pulisher
May 21, 2025

Janus Henderson Group PLC Cuts Stock Holdings in Immunic, Inc. (NASDAQ:IMUX) - Defense World

May 21, 2025
pulisher
May 20, 2025

Immunic, Inc. (NASDAQ:IMUX) Receives $13.20 Average Price Target from Analysts - Defense World

May 20, 2025
pulisher
May 16, 2025

Immunic: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 15, 2025

Barclays PLC Takes $84,000 Position in Immunic, Inc. (NASDAQ:IMUX) - Defense World

May 15, 2025
pulisher
May 12, 2025

Immunic (IMUX) Projected to Post Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 09, 2025

Immunic CMO on Celiac Disease Awareness Month, potential of IMU-856 - Proactive financial news

May 09, 2025
pulisher
May 08, 2025

Reviewing Psyence Biomedical (NASDAQ:PBM) and Immunic (NASDAQ:IMUX) - Defense World

May 08, 2025
pulisher
May 07, 2025

Immunic eyes Phase 3 after MS disability gains in Phase 2 CALLIPER trial - Proactive financial news

May 07, 2025
pulisher
May 06, 2025

36,811 Shares in Immunic, Inc. (NASDAQ:IMUX) Acquired by Invesco Ltd. - Defense World

May 06, 2025
pulisher
May 06, 2025

Immunic (IMUX) Stock Price, News & Analysis - MarketBeat

May 06, 2025
pulisher
May 05, 2025

Where Do Analysts See Immunic Inc (NASDAQ: IMUX) Heading? - Stocksregister

May 05, 2025

Finanzdaten der Immunic Inc-Aktie (IMUX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):